Sarcopenia Prevalence and Associated Factors in an Elderly <scp>T</scp>aiwanese <scp>M</scp>etropolitan Population

Lin, Cheng‐Chieh; Lin, Wen‐Yuan; Meng, Nai‐Hsin; Li, Chia‐Ing; Liu, Chiu-Shong; Lin, Chih‐Hsueh; Chang, Chiu-Kai; Lee, Yih-Dar; Lee, Cheng-Chun; Li, Tsai‐Chung

doi:10.1111/jgs.12129

Cited by 48 publications

(41 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, the lack of consensus diagnostic criteria makes it difficult to compare different studies to determine the true prevalence of sarcopenia in these various populations. Since the EWGSOP consensus was established, studies have become more comparable, allowing researchers to create a ‘global map’ of sarcopenia, which has revealed prevalences ranging from 5 to 33% in the various regions evaluated …”

Section: Introductionmentioning

confidence: 99%

Prevalence of sarcopenia among community-dwelling elderly of a medium-sized South American city: results of theCOMO VAI? study

Barbosa-Silva

Bielemann

Gonzalez

et al. 2015

Journal of Cachexia, Sarcopenia and Muscle

190

151

View full text Add to dashboard Cite

BackgroundThere is insufficient data concerning sarcopenia prevalence in South America. The aim of this study was to estimate sarcopenia prevalence and its clinical subgroups in a Southern Brazilian city.MethodsA cross‐sectional population‐based study was performed among community‐dwelling elderly aged 60 years or over. Subjects were evaluated according to the European Working Group on Sarcopenia in Older People established criteria. Muscle mass was estimated by calf circumference (CC). Cut‐off CC points were defined by a subsample's dual X‐ray absorptiometry estimation of the appendicular skeletal muscle mass index (ASMI), which was subsequently compared with the values of a young adult population from the same city. Muscle strength was measured by manual dynamometry. Muscle performance was assessed through the 4 m gait speed test.ResultsThe three diagnostic tests were performed in 1291 subjects. CC of ≤34 cm (males) and ≤33 cm (females) were defined as indicatives of low ASMI. The overall sarcopenia prevalence was 13.9% (CI95% 12.0; 15.8%). Its frequency was significantly higher among elderly with low schooling, without a partner, with low socioeconomic status, smokers, inactive, and with low body mass index. A higher prevalence of pre‐sarcopenia was found in the youngest elderly; a higher prevalence of the clinical stages of the syndrome was found in older age groups.ConclusionsApproximately one in ten elderly aged 60–69 years was in the preclinical stage of the disease. This is the age group in which public policies should focus to establish early diagnosis and prevent clinical progression of the syndrome.

show abstract

Section: Introductionmentioning

confidence: 99%

Prevalence of sarcopenia among community-dwelling elderly of a medium-sized South American city: results of theCOMO VAI? study

Barbosa-Silva

Bielemann

Gonzalez

et al. 2015

Journal of Cachexia, Sarcopenia and Muscle

190

151

View full text Add to dashboard Cite

show abstract

“…The prevalence of sarcopenia among community-dwelling people in Taiwan ranged from 7.1 to 30.9% (29). In this study, the prevalence of sarcopenia was 6.8% by using the AWGS diagnostic criteria (25).…”

Section: Discussionmentioning

confidence: 99%

Association of Dynapenia, Sarcopenia, and Cognitive Impairment Among Community-Dwelling Older Taiwanese

Huang

Hwang

Liu

et al. 2016

Rejuvenation Research

110

View full text Add to dashboard Cite

A decline in physical and/or cognitive function is a common feature of aging, and frailty has been shown to be associated with cognitive impairment and dementia. This study aimed to evaluate the association between dynapenia, sarcopenia, and cognitive impairment among community-dwelling older people in Taiwan. Data from the I-Lan Longitudinal Aging Study (ILAS) were retrieved for study. Global cognitive function was assessed by Mini-Mental State Examination (MMSE), whereas the Chinese Version Verbal Learning Test, Boston Naming Test, Verbal Fluency Test, Taylor Complex Figure Test, Digits Backward Test, and Clock Drawing Test were used to assess different domains of cognitive function. Association between sarcopenia and global cognitive function as well as all different dimensions of cognitive function were evaluated. Data from 731 elderly participants (mean age 73.4 ± 5.4 years, 53.8% males) were used for study analysis. The overall prevalence of sarcopenia was 6.8%, which was significantly higher in men (9.3% versus 4.1%, p < 0.05). The mean MMSE score was 23.4 ± 4.4 for all participants, and 10.3% of the study participants were cognitively impaired. Sarcopenia was not significantly associated with global cognitive function (odds ratio [OR] = 1.55, p = 0.317), but global cognitive impairment was significantly associated with low physical performance (OR = 2.31, p = 0.003) and low muscle strength (OR = 2.59, p = 0.011). Nonetheless, sarcopenia was significantly associated with impairment in the verbal fluency test (OR = 3.96, p = 0.006) after adjustment for potential confounders. Dynapenia was significantly associated with cognitive impairment in multiple dimensions and global cognitive function, but sarcopenia was only associated with an impaired verbal fluency test. Reduced muscle strength and/or physical performance related to non-muscle etiology were strongly associated with cognitive impairment. More longitudinal studies are needed.

show abstract

“…Most of the previous studies were conducted on elderly people over 60 years of age [12,16], but relatively few studies have focused on differences by age in the general population. Most studies focus on the relationship between sarcopenia and the individual factors [4,17].…”

Section: Introductionmentioning

confidence: 99%

Factors Affecting Sarcopenia in Korean Adults by Age Groups

Bae

Kim

2017

Osong Public Health Res Perspect

View full text Add to dashboard Cite

ObjectivesThis study aimed to investigate factors affecting sarcopenia in different age groups among Korean adults aged 20 years or older.MethodsIn this secondary analysis, data were collected from records for 17,968, participants who participated in the Korea National Health and Nutrition Examination Survey during 2008–2011. Data were analyzed using multiple logistic regression to determine the associated factors of sarcopenia by age groups.ResultsThe prevalence of sarcopenia increased significantly with age. Physical activity, blood pressure, waist circumference, triglycerides, vitamin D level were found to be factors significantly associated with sarcopenia in all age groups. Total energy intake was found to be a factor that is significantly associated with sarcopenia among the adults aged 20–39 years. Fasting glucose, suicidal ideation, perceived health status, mobility problem, pain/discomfort, total energy intake were found to be factors associated with sarcopenia in the adults aged 40–64 years. Sex, residential area, smoking, drinking, fasting glucose, osteoarthritis, fall experience, usual activity problem, protein intake were factors associated with sarcopenia in the adults over 65 years of age.ConclusionThe findings show that sarcopenia in adults and the associated factors were different by age groups. Thus, these factors should be considered in the development of intervention programs for the care and prevention of sarcopenia, and such programs should be modified according to different age groups.

show abstract

Sarcopenia Prevalence and Associated Factors in an Elderly Taiwanese Metropolitan Population

Cited by 48 publications

References 10 publications

Prevalence of sarcopenia among community-dwelling elderly of a medium-sized South American city: results of theCOMO VAI? study

Prevalence of sarcopenia among community-dwelling elderly of a medium-sized South American city: results of theCOMO VAI? study

Association of Dynapenia, Sarcopenia, and Cognitive Impairment Among Community-Dwelling Older Taiwanese

Factors Affecting Sarcopenia in Korean Adults by Age Groups

Contact Info

Product

Resources

About